Lanxess AG
F:LXS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lanxess AG
F:LXS
|
DE |
|
Lineage Cell Therapeutics Inc
F:BT3
|
US |
|
R
|
Reckitt Benckiser Group PLC
XBER:3RB
|
UK |
|
L
|
Live Ventures Inc
F:UYXP
|
US |
|
D
|
Deutsche Boerse AG
DUS:DB1
|
DE |
|
Bayerische Motoren Werke AG
MIL:1BMW
|
DE |
|
B
|
BKW AG
SWB:B9W
|
CH |
|
G
|
Graincorp Ltd
XMUN:G3C
|
AU |
|
I
|
InterDigital Inc
XBER:IDI
|
US |
|
W
|
Westlake Corp
XMUN:UEO
|
US |
Dividends
Dividend Yield
Lanxess AG
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Lanxess AG
LXS have decreased by 80%.
Payout Ratio
Lanxess AG
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for LXS is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
LXS Price
Lanxess AG
| Average Annual Return | -19.1% |
| Standard Deviation of Annual Returns | 10.1% |
| Max Drawdown | -81% |
| Market Capitalization | 1.3B EUR |
| Shares Outstanding | 86 346 304 |
| Percentage of Shares Shorted |
N/A
|
